Decision Diagnostics

DECN · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About DECN

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The firm is specialized in prescription, non-prescription diagnostics and home testing products. The company is a provider of prescription drugs, home testing products for the chronically ill, a fulfillment provider of direct to patient diabetes programs, and a developer of cell phone centric, e-health products and technology. Through its subsidiary, PharmaTech Solutions, Inc., the Company provides blood glucose home testing devices like GenUltimate! and PetSure! test strips and GenUltimate!4Pets monitoring system. The company also provides smart phone based electronic medical record (EMR) applications to be used by physicians at the point of care. These mobile applications allow physicians to access and update their patients' histories, medication data and care guidelines. The firm develops products that offer solutions to medical care professionals and management by providing physicians with essential information.

Employees
0
Headquarters
Westlake Village, California
Listed
Feb 8, 2002
Sector
Health Care
Industry
Health Care Technology

Leadership

Decision Diagnostics executives
NameTitle
Robert Jagunich—
William Lyons—

Similar companies

Companies in the same industry as Decision Diagnostics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.